Management of intestinal transplantation in humans

Transplant Proc. 1992 Jun;24(3):1243-4.

Abstract

We report here the clinical experience and management guidelines for the nine consecutive cases who received either an isolated small intestinal graft (n = 1) or an intestine liver combination at the University of Pittsburgh, with FK 506 being the basic immunosuppressive drug therapy.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Child
  • Female
  • Gastrointestinal Motility
  • Graft Rejection
  • Humans
  • Intestine, Small / physiology
  • Intestine, Small / transplantation*
  • Male
  • Postoperative Complications / therapy
  • Tacrolimus / therapeutic use
  • Transplantation, Homologous / immunology
  • Transplantation, Homologous / physiology
  • Treatment Outcome

Substances

  • Tacrolimus